Posted inResearch
Breast cancer tops list of most-studied diseases for 5th year in a row: report
Phesi’s report of the world’s most-studied diseases has become a holiday tradition, and this year’s list features few surprises. Breast…
Posted inResearch
Lindus Health and Quotient team up to create one-stop shop for early to mid-stage trials
Clinical development accelerator Quotient Sciences and CRO Lindus Health are joining forces to create a streamlined process for clients to…
Posted inResearch
Leading the Way in Biotech Solutions Across Japan and Asia Pacific (JAPAC)
Sponsored By IQVIA Dec 15, 2025 8:00am Unmatched expertise in patient recruitment and retentionOne of the critical challenges in clinical…
Posted inResearch
FDA qualifies 1st AI drug development tool for reading MASH images
The FDA has qualified its first artificial intelligence tool to help drug developers evaluate fatty liver disease in their clinical…
Posted inResearch
Paradigm Health raises $78M to revamp clinical research process, inks deal with Roche’s Flatiron
Paradigm Health has raised $78 million as it works to revamp the clinical research ecosystem, while also revealing a deal…
Posted inResearch
Next-gen CRO Avetra unveils with access to 350-plus US sites
A new CRO called Avetra has emerged with a mission of modernizing clinical research operations by prioritizing transparency and faster…
Posted inResearch
JSR hands over Crown to Carlyle-backed lab service company in $204M deal
JSR Life Sciences is parting ways with its CRO business Crown Bioscience, selling the unit to a Chinese clinical lab…
Posted inResearch
Charles River lays off about 70 staffers in relocation as strategic shift begins
Charles River Laboratories is laying off staff at one of its East Coast sites just over a week after announcing…
Posted inResearch
BMS boosts cancer trials with Sarah Cannon’s clinical research platform
Bristol Myers Squibb is expanding a partnership with oncology organization Sarah Cannon Research Institute (SCRI), tapping into the institute’s community-based…
Posted inResearch
Charles River to cuts costs, shift direction as revenue slide continues
The board of Charles River Laboratories has completed a strategic review of the company, deciding to cut costs and shift…